Historical record - last NADAC effective date: 8/22/2018
Product Information
TAMSULOSIN HCL 0.4 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.1046 per EA under NDC 00115821101. Its NADAC has been published 250 times since Nov 28, 2013.
FDA first approved this application on Mar 2, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the TAMSULOSIN HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.4 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115821101
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/22/2018
Active Ingredients
TAMSULOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090377FDA Approved
3/2/2010
TE Code
AB
On Market Since
4/1/2025
Pharmacological Classes
Price Statistics
The NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has been published 250 times since Nov 28, 2013, and over the history we have for it it has declined 23.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1046 per EA |
|---|---|
| All-time high | $0.5414 (Dec 10, 2014) |
| All-time low | $0.0924 (Jul 18, 2018) |
| Median price | $0.1656 |
| Average price | $0.2225 |
| Largest weekly change | +131.0% (Nov 12, 2014) |
| Weeks tracked | 250 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-23.7%
Last surveyed Sep 5, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TAMSULOSIN HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TAMSULOSIN HCL 0.4 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TAMSULOSIN HCL 0.4 MG CAPSULE, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.1046 per EA (NDC 00115821101), effective Sep 5, 2018.
How has the price of TAMSULOSIN HCL 0.4 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has declined 23.7%. It has been tracked across 250 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TAMSULOSIN HCL 0.4 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has ranged from a low of $0.0924 (Jul 18, 2018) to a high of $0.5414 (Dec 10, 2014), with a median of $0.1656 per EA.
Are there cheaper alternatives to TAMSULOSIN HCL 0.4 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of TAMSULOSIN HCL 0.4 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TAMSULOSIN HCL 0.4 MG CAPSULE?
TAMSULOSIN HCL 0.4 MG CAPSULE (NDC 00115821101) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.